novo nordisk semaglutide india to launch Ozempic in India, sets stage for GLP-1 market expansion Novo Nordisk moves Delhi HC
Description
This once-weekly injectable is part of the trusted Wegovy protocol, FDA-approved for chronic weight management in adults with obesity or weight-related health conditions
Summary Remember, maintaining a healthy weight involves more than just dieting
Semaglutide works by reducing appetite and slowing digestion, but visible results take time
Additionally, the loss of fatty acids can affect the skin barrier, leading to dryness and a lacklustre appearance
